The leading conferences in genome editing, cell lines, protein therapeutics, and bioconjugation have come together to create a platform for research scientists, biologists, and bioengineers can discuss the latest breakthroughs, technologies, and discoveries.
Exploring the latest breakthroughs and results from the ever expanding number of protein molecules in development to accelerate the discovery, engineering, and development of alternative scaffolds and novel protein therapeutics to create differentiated drugs.
With the latest insights and advances in developing protein molecules, the Next Generation Protein Therapeutics conference will deliver:
Cases studies and new data on multispecific proteins, bispecific proteins, and novel protein molecules currently in development
Insights from academic visionaries and industry experts on clinical breakthroughs and updates for scaffolds, antibody fragments, peptides, and immunotherapies
Emerging methods and technologies for screening, selection, and sequencing of proteins to accelerate discovery
"This conference is one of the best IBC conferences I have ever attended. I like the new ideas and active discussions in the meeting"- Liang Tang, Principal Scientist, Bayer Healthcare
IBC Life Sciences is part of Informa PLC which operates at the heart of the Knowledge and Information Economy Phone: 800.390.4078Email: firstname.lastname@example.org